Candel Therapeutics, Inc. (CADL)
NASDAQ·Healthcare·Biotechnology
$9.56
-1.24%
Mkt Cap $700.46M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+56.9%
Consensus $15.00 vs current $9.56
NASDAQ·Healthcare·Biotechnology
$9.56
-1.24%
Mkt Cap $700.46M
Buy
3
Hold
0
Sell
0
Price Target (1 analysts)
$15.00
Range $15.00 – $15.00
+56.9%
Consensus $15.00 vs current $9.56